Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
HHS-FDA Forecasted FOR-FD-25-009Description
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of pre-clinical studies of anesthetic neurotoxicity. Multiple awards may be considered. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders.
Funding Details
- Award Floor
- $2,000,000.00
- Award Ceiling
- $2,000,000.00
- Total Estimated Funding
- Not specified
- Expected Awards
- 5
Key Dates
- Posted
- August 14, 2024
- Closes
- N/A
- Archive Date
- N/A
Agency Information
- Agency Name
- HHS-FDA
- Agency Code
- HHS-FDA
- Funding Instrument
- Other